Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1613-7671
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna ; day:27 ; month:1 ; year:2017 ; pages:1-10
Wiener klinische Wochenschrift ; (27.1.2017), 1-10
- Urheber
-
Steiner, Sebastian
- Beteiligte Personen und Organisationen
-
Bucsics, Theresa
Schwabl, Philipp
Mandorfer, Mattias
Scheiner, Bernhard
Aichelburg, Maximilian Christopher
Grabmeier-Pfistershammer, Katharina
Ferenci, Peter
Trauner, Michael
Peck-Radosavljevic, Markus
Reiberger, Thomas
SpringerLink (Online service)
- DOI
-
10.1007/s00508-016-1162-y
- URN
-
urn:nbn:de:1111-2017022210169
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Steiner, Sebastian
- Bucsics, Theresa
- Schwabl, Philipp
- Mandorfer, Mattias
- Scheiner, Bernhard
- Aichelburg, Maximilian Christopher
- Grabmeier-Pfistershammer, Katharina
- Ferenci, Peter
- Trauner, Michael
- Peck-Radosavljevic, Markus
- Reiberger, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
Novel biomarkers assist in detection of liver fibrosis in HCV patients
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
Novel biomarkers assist in detection of liver fibrosis in HCV patients
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)